Ovarian cancer think tank: An overview of the current status of ovarian cancer screening and recommendations for future directions

Julia M Dexter; Lindsay W Brubaker; Benjamin G Bitler; Barbara A Goff; Usha Menon; Katherine N Moore; Karthik M Sundaram; Christine S Walsh; Saketh R Guntupalli; Kian Behbakht

doi:10.1016/j.gore.2024.101376

Ovarian cancer think tank: An overview of the current status of ovarian cancer screening and recommendations for future directions

Gynecol Oncol Rep. 2024 Mar 27:53:101376. doi: 10.1016/j.gore.2024.101376. eCollection 2024 Jun.

Affiliations

¹ Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The University of Colorado, Aurora, CO, USA.
² Department of OB/GYN, Division of Reproductive Sciences, The University of Colorado, Aurora, CO, USA.
³ Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
⁴ MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.
⁵ Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
⁶ Department of Radiology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.

Abstract

Early diagnosis and screening of ovarian cancer remain significant challenges to improving patient outcomes. There is an urgent need to implement both established and modern strategies to address the "early detection" conundrum, especially as new research continues to uncover the complexities of the disease. The discussion provided is the result of a unique research conference focused on reviewing early detection modalities and providing insight into future approaches.

Keywords: Artificial intelligence; Early detection; Prevention; Screening; Tubo-ovarian malignancy.